The clinical value of fluid biomarkers for dementia diagnosis

Suzanne M Dyer¹, Leon Flicker², Kate Laver³, Craig Whitehead³, Robert Cumming⁴

Affiliations

¹ Department of Rehabilitation, Aged and Extended Care, School of Health Sciences, Flinders University, Adelaide, SA, Australia; NHMRC Partnership Centre in Cognitive and Functional Decline, The University of Sydney, Sydney, NSW, Australia. Electronic address: suzanne.dyer@sa.gov.au.
² Centre for Medical Research, University of Western Australia, Crawley, WA, Australia.
³ Department of Rehabilitation, Aged and Extended Care, School of Health Sciences, Flinders University, Adelaide, SA, Australia; NHMRC Partnership Centre in Cognitive and Functional Decline, The University of Sydney, Sydney, NSW, Australia.
⁴ School of Public Health, The University of Sydney, Sydney, NSW, Australia.

PMID: 27751543
DOI: 10.1016/S1474-4422(16)30238-1

Comment

The clinical value of fluid biomarkers for dementia diagnosis

Suzanne M Dyer et al. Lancet Neurol. 2016 Nov.

. 2016 Nov;15(12):1204.

doi: 10.1016/S1474-4422(16)30238-1. Epub 2016 Oct 11.

Authors

Suzanne M Dyer¹, Leon Flicker², Kate Laver³, Craig Whitehead³, Robert Cumming⁴

Affiliations

¹ Department of Rehabilitation, Aged and Extended Care, School of Health Sciences, Flinders University, Adelaide, SA, Australia; NHMRC Partnership Centre in Cognitive and Functional Decline, The University of Sydney, Sydney, NSW, Australia. Electronic address: suzanne.dyer@sa.gov.au.
² Centre for Medical Research, University of Western Australia, Crawley, WA, Australia.
³ Department of Rehabilitation, Aged and Extended Care, School of Health Sciences, Flinders University, Adelaide, SA, Australia; NHMRC Partnership Centre in Cognitive and Functional Decline, The University of Sydney, Sydney, NSW, Australia.
⁴ School of Public Health, The University of Sydney, Sydney, NSW, Australia.

PMID: 27751543
DOI: 10.1016/S1474-4422(16)30238-1

No abstract available

PubMed Disclaimer

Comment in

The clinical value of fluid biomarkers for dementia diagnosis - Authors' reply.
Olsson B, Blennow K, Zetterberg H. Olsson B, et al. Lancet Neurol. 2016 Nov;15(12):1204-1205. doi: 10.1016/S1474-4422(16)30247-2. Epub 2016 Oct 11. Lancet Neurol. 2016. PMID: 27751544 No abstract available.

Comment on

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
Olsson B, Lautner R, Andreasson U, Öhrfelt A, Portelius E, Bjerke M, Hölttä M, Rosén C, Olsson C, Strobel G, Wu E, Dakin K, Petzold M, Blennow K, Zetterberg H. Olsson B, et al. Lancet Neurol. 2016 Jun;15(7):673-684. doi: 10.1016/S1474-4422(16)00070-3. Epub 2016 Apr 8. Lancet Neurol. 2016. PMID: 27068280

Cited by

Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.
Chiotis K, Dodich A, Boccardi M, Festari C, Drzezga A, Hansson O, Ossenkoppele R, Frisoni G, Garibotto V, Nordberg A. Chiotis K, et al. Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2086-2096. doi: 10.1007/s00259-021-05277-4. Epub 2021 Mar 15. Eur J Nucl Med Mol Imaging. 2021. PMID: 33723628 Free PMC article. Review.
Methodological Issues in the Clinical Validation of Biomarkers for Alzheimer's Disease: The Paradigmatic Example of CSF.
Canevelli M, Bacigalupo I, Gervasi G, Lacorte E, Massari M, Mayer F, Vanacore N, Cesari M. Canevelli M, et al. Front Aging Neurosci. 2019 Oct 17;11:282. doi: 10.3389/fnagi.2019.00282. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31680936 Free PMC article. Review.
Biomarker Testing: Piercing the Fog of Alzheimer's and Related Dementia.
Horgan D, Nobili F, Teunissen C, Grimmer T, Mitrecic D, Ris L, Pirtosek Z, Bernini C, Federico A, Blackburn D, Logroscino G, Scarmeas N. Horgan D, et al. Biomed Hub. 2020 Nov 23;5(3):19-40. doi: 10.1159/000511233. eCollection 2020 Sep-Dec. Biomed Hub. 2020. PMID: 33564663 Free PMC article.
Reproducibility of Alzheimer's Disease Cerebrospinal Fluid-Biomarker Measurements under Clinical Routine Conditions.
Vogelgsang J, Wedekind D, Bouter C, Klafki HW, Wiltfang J. Vogelgsang J, et al. J Alzheimers Dis. 2018;62(1):203-212. doi: 10.3233/JAD-170793. J Alzheimers Dis. 2018. PMID: 29439341 Free PMC article.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The clinical value of fluid biomarkers for dementia diagnosis

Affiliations

The clinical value of fluid biomarkers for dementia diagnosis

Authors

Affiliations

Comment in

Comment on

Similar articles

Cited by

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources